Clinical Trial Update: The Safety of Using Buprenorphine With Naloxone in a Buccal Film to Initiate Treatment of Opioid Dependent Subjects [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating buprenorphine/naloxone buccal film to initiate treatment in individuals with opioid use disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine/naloxone buccal film (Buprenorphine; Naloxone)

Snippet

Sponsor: BioDelivery Sciences International | Conditions: Opioid Dependence | Phase 3 | Status: WITHDRAWN